Streetbeat News

Regulatory

BGNE

BeiGene, Ltd. announced it will present new data from its hematology portfolio and pipeline at EHA2024, including studies on BRUKINSA, sonrotoclax, and BGB-16673, showcasing promising results in treatment-naive CLL/SLL patients and BTK inhibitor resistant disease.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:17 pm

GOOGL

RUM

Rumble has filed a second antitrust lawsuit against Google, alleging monopolization of the online advertising market, with damages exceeding $1B. This lawsuit is distinct from the January 2021 self-preferencing case, which is still in discovery and set for trial in May 2025.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:14 pm

META

Robert F. Kennedy Jr., running as an Independent for the 2024 presidential election, has filed a lawsuit against Meta Platforms (NASDAQ:META), and CEO Mark Zuckerberg, accusing them of suppressing a campaign ad and interfering with the election. Meta claims the ad's removal was accidental and quickly rectified. The lawsuit highlights broader concerns about social media's role in elections and potential biases.

Portfolio Pulse from Chris Katje

May 14, 2024 | 8:10 pm

QGEN

Qiagen has announced that its clinical decision support software, QIAGEN Clinical Insight Interpret, has received the European IVDR certification. This certification allows the software to be used for NGS molecular profiling of hereditary and somatic diseases within the EU.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:09 pm

ALLR

Allarity Therapeutics, Inc. (ALLR) announced positive outcomes from its Phase 2 trial of Stenoparib, showing clear clinical benefits. The company also reported improvements in its financial position, with a cash balance of $14M and equity balances of $15M. Additionally, Allarity is on track to regain compliance with Nasdaq listing requirements, has no variable priced securities outstanding, and has nearly eliminated warrant overhang. The company has withdrawn its Form S-1, signaling a strategic shift or achievement of required funding through other means.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:09 pm

CRIS

Curis, Inc. announced an update on its TakeAim Leukemia study, expanding the AML dataset from 5 to 30 patients. The update will be presented at the ASCO and EHA conferences, including data for 25 new patients treated with emavusertib.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:02 pm

BEAM

Beam Therapeutics Inc. announced it will present data on the manufacturing process for BEAM-101 at the EHA 2024 Hybrid Congress. The data highlights a robust, closed, and automated process used in the BEACON Phase 1/2 clinical trial for sickle cell disease treatment.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:00 pm

MAG

MAG Silver Corp. has filed a preliminary short form base shelf prospectus in Canada and plans to file a corresponding registration statement in the U.S. This will allow the company to offer up to $250M of various securities over a 25-month period once the final prospectus is effective.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 7:44 pm

BTCUSD

ETHUSD

A report by 10x Research suggests this week's inflation data could cause volatility for Bitcoin, with a potential +/-6% price move. The report advises buying Bitcoin if bullish and shorting Ethereum if bearish, ahead of the inflation data release. It also notes Bitcoin's support level around $60,800-$61,400 and the average entry price for Bitcoin ETFs at $57,000. The report predicts a meaningful rally for Bitcoin later in the year, despite immediate headwinds and a potentially pivotal SEC decision on an Ethereum ETF.

Portfolio Pulse from Murtuza Merchant

May 14, 2024 | 7:29 pm